Retatrutide has moved from an early-stage peptide research candidate into a much broader clinical development program. During 2026, new Phase 3 results expanded the available research data across obesity, type 2 diabetes, cardiovascular disease, knee osteoarthritis, and other related areas. The research is attracting attention because retatrutide is designed as a triple hormone receptor agonist,[ Read more…]
Tag Archives: Peptide Research
12
Jan
Jan
Choosing a peptide supplier is not just a purchasing decision, it’s a quality decision that directly impacts research accuracy, consistency, and confidence. With the growing number of peptide websites available today, it has become increasingly difficult to separate reliable suppliers from those that simply focus on accessibility and price. Two names that frequently come up[ Read more…]